HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality

N Mühlberger, R Schwarzer, B Lettmeier… - BMC public health, 2009 - Springer
Abstract Background Hepatitis C virus (HCV) is a leading cause of chronic liver disease, end-
stage cirrhosis, and liver cancer, but little is known about the burden of disease caused by …

Integration of palliative care in end-stage liver disease and liver transplantation

J Potosek, M Curry, M Buss… - Journal of palliative …, 2014 - liebertpub.com
Background: Patients with end-stage liver disease (ESLD) have a life-limiting illness that
causes multiple distressing symptoms and negatively affects quality of life (QOL). This …

Symptom clusters: myth or reality?

A Aktas, D Walsh, L Rybicki - Palliative medicine, 2010 - journals.sagepub.com
Clinical experience suggests that many symptoms occur together. In this paper, we examine
the rationale and evidence base for symptom clusters in different medical fields, particularly …

Uncertainty, symptoms, and quality of life in persons with chronic hepatitis C

DE Bailey Jr, L Landerman, J Barroso, P Bixby… - Psychosomatics, 2009 - Elsevier
Background Chronic hepatitis C (CHC) is the most common blood-borne infection in the
United States, but little is known about illness uncertainty in these patients. Objective The …

Living with chronic hepatitis C meansyou just haven't got a normal life any more'

S Conrad, LE Garrett, WGE Cooksley… - Chronic …, 2006 - journals.sagepub.com
Objective: To explore psychosocial factors that impact on quality of life for people living with
self-reported chronic hepatitis C. Methods: A purposeful sample of 70 people who were self …

Patient-reported symptoms during and after direct-acting antiviral therapies for chronic hepatitis C: the PROP UP study

DM Evon, S Sarkar, J Amador, AS Lok, RK Sterling… - Journal of …, 2019 - Elsevier
Background & Aims A comprehensive analysis of changes in symptoms and functioning
during and after direct-acting antiviral (DAA) therapy for chronic hepatitis C virus (HCV) …

Fatigue before, during and after antiviral therapy of chronic hepatitis C: results from the Virahep-C study

S Sarkar, Z Jiang, DM Evon, AS Wahed… - Journal of …, 2012 - Elsevier
BACKGROUND & AIMS: Fatigue is the most frequent and often debilitating symptom of
chronic hepatitis C. It is unclear whether successful therapy of hepatitis C leads to its clinical …

[HTML][HTML] Sleep disorder in patients with chronic liver disease: a narrative review

NM Shah, AM Malhotra, G Kaltsakas - Journal of Thoracic Disease, 2020 - ncbi.nlm.nih.gov
Sleep disturbance is a common feature of chronic liver disease (CLD) with impact on health-
related quality of life; 60–80% of patients with CLD report subjective poor sleep; frequent …

A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy …

DM Evon, PW Stewart, J Amador, M Serper, AS Lok… - PloS one, 2018 - journals.plos.org
Background Symptom burden, medical comorbidities, and functional well-being of patients
with chronic hepatitis C virus (HCV) initiating direct acting antiviral (DAA) therapy in real …

Irritability in mood disorders: neurobiological underpinnings and implications for pharmacological intervention

E Bell, P Boyce, RJ Porter, RA Bryant, GS Malhi - CNS drugs, 2021 - Springer
Feeling irritable is a common experience, both in health and disease. In the context of
psychiatric illnesses, it is a transdiagnostic phenomenon that features across all ages, and …